tiprankstipranks
Crescita Therpeutc J (TSE:CTX)
TSX:CTX
Canadian Market
CTX
Crescita Therpeutc
RESEARCH TOOLSreports
Want to see TSE:CTX full AI Analyst Report?

Crescita Therpeutc (CTX) Ratios

12 Followers

Crescita Therpeutc Ratios

TSE:CTX's free cash flow for Q4 2025 was C$0.51. For the 2025 fiscal year, TSE:CTX's free cash flow was decreased by C$ and operating cash flow was C$-0.06. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.33 3.33 2.77 3.80 3.39
Quick Ratio
 2.33 2.33 2.04 2.54 2.46
Cash Ratio
 1.82 1.82 1.68 1.93 1.36
Solvency Ratio
 0.30 0.30 -0.23 -0.08 0.32
Operating Cash Flow Ratio
 0.23 0.23 0.49 0.43 -0.17
Short-Term Operating Cash Flow Coverage
 3.21 3.21 5.81 0.00 0.00
Net Current Asset Value
C$ 10.97MC$ 10.97MC$ 9.36MC$ 12.71MC$ 13.13M
Leverage Ratios
Debt-to-Assets Ratio
 0.02 0.02 0.04 0.05 0.06
Debt-to-Equity Ratio
 0.02 0.02 0.05 0.07 0.08
Debt-to-Capital Ratio
 0.02 0.02 0.05 0.06 0.07
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.31 1.31 1.38 1.31 1.35
Debt Service Coverage Ratio
 4.69 1.25 -2.47 -4.84 16.13
Interest Coverage Ratio
 -24.33 -24.33 -49.46 -23.01 4.63
Debt to Market Cap
 0.02 0.04 0.04 0.00 0.00
Interest Debt Per Share
 0.02 0.02 0.05 0.07 0.09
Net Debt to EBITDA
 -4.65 -17.21 6.33 -180.69 -3.17
Profitability Margins
Gross Profit Margin
54.28%49.12%49.07%59.15%56.03%
EBIT Margin
1.29%-4.84%-13.78%-8.34%2.25%
EBITDA Margin
8.40%2.27%-6.81%0.26%8.88%
Operating Profit Margin
-4.84%-4.84%-16.42%-11.16%3.11%
Pretax Profit Margin
-0.39%-0.39%-14.12%-8.73%1.72%
Net Profit Margin
-0.44%-0.44%-14.04%-11.33%3.66%
Continuous Operations Profit Margin
-0.44%-0.44%-14.04%-11.33%3.66%
Net Income Per EBT
110.84%110.84%99.49%129.80%213.37%
EBT Per EBIT
8.12%8.12%85.97%78.22%55.19%
Return on Assets (ROA)
-0.45%-0.45%-12.63%-8.07%3.03%
Return on Equity (ROE)
-0.59%-0.59%-17.37%-10.55%4.09%
Return on Capital Employed (ROCE)
-6.55%-6.55%-19.77%-9.91%3.26%
Return on Invested Capital (ROIC)
-6.41%-6.41%-18.60%-9.70%3.21%
Return on Tangible Assets
-0.49%-0.49%-13.72%-8.79%3.36%
Earnings Yield
-0.66%-1.02%-24.60%-20.01%6.31%
Efficiency Ratios
Receivables Turnover
 9.99 9.99 11.41 6.31 3.77
Payables Turnover
 2.23 2.48 2.00 1.66 1.85
Inventory Turnover
 2.04 2.28 2.46 1.17 1.83
Fixed Asset Turnover
 11.82 11.82 8.08 9.49 10.19
Asset Turnover
 1.04 1.04 0.90 0.71 0.83
Working Capital Turnover Ratio
 1.93 2.03 1.67 1.25 1.69
Cash Conversion Cycle
 51.15 49.67 -2.60 149.59 98.35
Days of Sales Outstanding
 36.52 36.52 31.99 57.81 96.80
Days of Inventory Outstanding
 178.51 160.40 148.28 312.33 199.24
Days of Payables Outstanding
 163.88 147.26 182.87 220.54 197.69
Operating Cycle
 215.03 196.92 180.27 370.13 296.05
Cash Flow Ratios
Operating Cash Flow Per Share
 0.06 0.06 0.14 0.10 -0.05
Free Cash Flow Per Share
 0.08 0.04 0.08 0.10 -0.06
CapEx Per Share
 0.02 0.02 0.06 <0.01 0.01
Free Cash Flow to Operating Cash Flow
 1.41 0.69 0.57 0.94 1.22
Dividend Paid and CapEx Coverage Ratio
 2.43 3.22 2.30 15.61 -4.45
Capital Expenditure Coverage Ratio
 2.43 3.22 2.30 15.61 -4.45
Operating Cash Flow Coverage Ratio
 3.21 3.21 3.27 1.66 -0.63
Operating Cash Flow to Sales Ratio
 0.05 0.05 0.14 0.12 -0.04
Free Cash Flow Yield
10.85%8.18%13.78%19.58%-9.15%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -151.74 -98.36 -4.06 -5.00 15.84
Price-to-Sales (P/S) Ratio
 0.66 0.43 0.57 0.57 0.58
Price-to-Book (P/B) Ratio
 0.90 0.58 0.71 0.53 0.65
Price-to-Free Cash Flow (P/FCF) Ratio
 9.21 12.23 7.26 5.11 -10.93
Price-to-Operating Cash Flow Ratio
 13.01 8.43 4.10 4.78 -13.39
Price-to-Earnings Growth (PEG) Ratio
 0.92 1.02 -0.09 0.01 -0.09
Price-to-Fair Value
 0.90 0.58 0.71 0.53 0.65
Enterprise Value Multiple
 3.22 1.68 -2.05 39.87 3.36
Enterprise Value
 5.72M 805.95K 2.74M 1.79M 7.03M
EV to EBITDA
 3.22 1.68 -2.05 39.87 3.36
EV to Sales
 0.27 0.04 0.14 0.10 0.30
EV to Free Cash Flow
 3.77 1.09 1.78 0.92 -5.63
EV to Operating Cash Flow
 5.33 0.75 1.01 0.86 -6.89
Tangible Book Value Per Share
 0.76 0.75 0.73 0.83 0.88
Shareholders’ Equity Per Share
 0.84 0.83 0.82 0.93 1.02
Tax and Other Ratios
Effective Tax Rate
 -0.11 -0.11 <0.01 -0.30 -1.13
Revenue Per Share
 1.13 1.12 1.02 0.87 1.14
Net Income Per Share
 >-0.01 >-0.01 -0.14 -0.10 0.04
Tax Burden
 1.11 1.11 0.99 1.30 2.13
Interest Burden
 -0.31 0.08 1.02 1.05 0.76
Research & Development to Revenue
 0.03 0.03 0.03 0.04 0.03
SG&A to Revenue
 0.51 0.51 0.55 0.58 0.00
Stock-Based Compensation to Revenue
 <0.01 0.00 <0.01 <0.01 <0.01
Income Quality
 -11.66 -11.66 -0.99 -1.05 -1.18
Currency in CAD